KOA SHOJI HOLDINGS CO.,LTD. Logo

KOA SHOJI HOLDINGS CO.,LTD.

Imports APIs and manufactures generic drugs for Japan's pharmaceutical industry.

9273 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
横浜市港北区日吉七丁目13−15
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

KOA SHOJI HOLDINGS CO., LTD. is a pharmaceutical holding group operating a dual business model that combines a trading company and a manufacturer. The group specializes in supporting the pharmaceutical industry "from upstream" by importing and distributing high-quality, safe, and reliable Active Pharmaceutical Ingredients (APIs) for the Japanese market. In addition to its core trading activities, the company also manufactures and sells generic drugs. Its integrated operations, which include contract manufacturing and packaging services, aim to provide a stable supply chain for its customers and address the healthcare needs of an aging society.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for KOA SHOJI HOLDINGS CO.,LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-20 03:20
Regulatory News Service
臨時報告書
Japanese 18.4 KB
2025-02-13 05:00
Interim Report
半期報告書-第11期(2024/07/01-2025/06/30)
Japanese 191.9 KB
2025-02-13 05:00
Regulatory News Service
確認書
Japanese 8.1 KB
2024-09-30 08:27
Regulatory News Service
臨時報告書
Japanese 24.6 KB
2024-09-30 08:26
Regulatory News Service
内部統制報告書-第10期(2023/07/01-2024/06/30)
Japanese 23.4 KB
2024-09-30 08:26
Regulatory News Service
確認書
Japanese 8.1 KB
2024-09-30 08:25
Annual Report
有価証券報告書-第10期(2023/07/01-2024/06/30)
Japanese 1.5 MB
2024-06-26 08:25
Regulatory News Service
臨時報告書
Japanese 18.4 KB
2024-06-05 09:30
Regulatory News Service
訂正有価証券届出書(参照方式)
Japanese 86.2 KB
2024-06-05 09:30
Regulatory News Service
訂正有価証券届出書(参照方式)
Japanese 171.1 KB
2024-05-27 08:00
Prospectus
有価証券届出書(参照方式)
Japanese 101.1 KB
2024-05-27 08:00
Prospectus
有価証券届出書(参照方式)
Japanese 250.3 KB
2024-05-13 08:30
Regulatory News Service
確認書
Japanese 8.1 KB
2024-05-13 08:30
Quarterly Report
四半期報告書-第10期第3四半期(2024/01/01-2024/03/31)
Japanese 156.7 KB
2024-02-14 07:30
Regulatory News Service
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all KOA SHOJI HOLDINGS CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for KOA SHOJI HOLDINGS CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Clinical-stage biopharma developing novel cancer drugs aiming for fewer side effects.
Japan 4575
Can-Fite BioPharma Ltd. Logo
Develops oral small-molecule drugs targeting A3AR for oncology and inflammatory diseases.
Israel CANF
Cannovum Cannabis AG Logo
Importer & producer of medical cannabis, expanding into recreational cultivation infrastructure.
Germany 27N0
Cantourage Group SE Logo
A European platform producing and distributing medical cannabis products to pharmacies.
Germany HIGH
CELADON PHARMACEUTICALS PLC Logo
Vertically integrated pharma developing cannabis medicines for chronic pain.
United Kingdom CEL
Cellectis Logo
Develops 'off-the-shelf' CAR T-cell cancer immunotherapies using TALEN® gene-editing.
France ALCLS
CellSeed Inc. Logo
Develops cell sheet products, culture equipment, and offers contract manufacturing services.
Japan 7776
CellSource Co.,Ltd. Logo
Processes patient-derived stem cells and PRP for regenerative therapies at medical facilities.
Japan 4880
Celon Pharma S.A. Logo
Researches, develops, and markets innovative drugs for oncology and neurology.
Poland CLN
Cessatech A/S Logo
Develops a non-invasive nasal spray for acute pain relief in children during medical procedures.
Denmark CESSA

Talk to a Data Expert

Have a question? We'll get back to you promptly.